Sign In
Buy MDGL
$531.00
-5.70 (-1.06%)
At Close: Jul 13, 2026
ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of Key Patents | | IT Business Net
03:11pm, Tuesday, 23'rd Jun 2020
Two Newly Issued Patents Further Protect ENDRA's TAEUS Platform Capabilities ANN ARBOR, MI / ACCESSWIRE / June 23, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a
Fate of Intercept's NASH drug clouded by murky FDA review delays
01:49pm, Tuesday, 23'rd Jun 2020
The agency had planned to announce its decision on whether or not to approve the first treatment for the fatty liver disease known as NASH this week.
Two Sigma Investments LP Purchases 15,717 Shares of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)
08:10am, Tuesday, 23'rd Jun 2020
Two Sigma Investments LP raised its position in shares of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) by 698.5% in the first quarter, according to the company in its most recent filing with the Securit
Ayala Pharmaceuticals (AYLA) Receives a Buy from Oppenheimer - Markets
03:14am, Tuesday, 23'rd Jun 2020
In a report released yesterday, Jay Olson from Oppenheimer maintained a Buy rating on Ayala Pharmaceuticals (AYLA – Research Report),
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
